Literature DB >> 7615785

A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians.

M Trommsdorff1, S Köchl, A Lingenhel, F Kronenberg, R Delport, H Vermaak, L Lemming, I C Klausen, O Faergeman, G Utermann.   

Abstract

The enormous interindividual variation in the plasma concentrations of the atherogenic lipoprotein(a) [Lp(a)] is almost entirely controlled by the apo(a) locus on chromosome 6q26-q27. A variable number of transcribed kringle4 repeats (K4-VNTR) in the gene explains a large fraction of this variation, whereas the rest is presently unexplained. We here have analyzed the effect of the K4-VNTR and of a pentanucleotide repeat polymorphism (TTTTA)n (n = 6-11) in the 5' control region of the apo(a) gene on plasma Lp(a) levels in unrelated healthy Tyroleans (n = 130), Danes (n = 154), and Black South Africans (n = 112). The K4-VNTR had a significant effect on plasma Lp(a) levels in Caucasians and explained 41 and 45% of the variation in Lp(a) plasma concentration in Tyroleans and Danes, respectively. Both, the pentanucleotide repeat (PNR) allele frequencies and their effects on Lp(a) concentrations were heterogeneous among populations. A significant negative correlation between the number of pentanucleotide repeats and the plasma Lp(a) concentration was observed in Tyroleans and Danes. The effect of the 5' PNRP on plasma Lp(a) concentrations was independent from the K4-VNTR and explained from 10 to 14% of the variation in Lp(a) concentrations in Caucasians. No significant effect of the PNRP was present in Black Africans. This suggests allelic association between PNR alleles and sequences affecting Lp(a) levels in Caucasians. Thus, in Caucasians but not in Blacks, concentrations of the atherogenic Lp(a) particle are strongly associated with two repeat polymorphisms in the apo(a) gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7615785      PMCID: PMC185183          DOI: 10.1172/JCI118015

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Characterization by yeast artificial chromosome cloning of the linked apolipoprotein(a) and plasminogen genes and identification of the apolipoprotein(a) 5' flanking region.

Authors:  N Malgaretti; F Acquati; P Magnaghi; L Bruno; M Pontoglio; M Rocchi; S Saccone; G Della Valle; M D'Urso; D LePaslier
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

2.  Slippage synthesis of simple sequence DNA.

Authors:  C Schlötterer; D Tautz
Journal:  Nucleic Acids Res       Date:  1992-01-25       Impact factor: 16.971

3.  A novel zinc finger cDNA with a polymorphic pentanucleotide repeat (ATTTT)n maps on human chromosome 19p.

Authors:  H Chen; M Kalaitsidaki; A C Warren; D Avramopoulos; S E Antonarakis
Journal:  Genomics       Date:  1993-03       Impact factor: 5.736

Review 4.  Genetic influences on lipoprotein(a) concentration.

Authors:  D P Wade; J G Clarke; G E Lindahl; A C Liu; B R Zysow; K Meer; K Schwartz; R M Lawn
Journal:  Biochem Soc Trans       Date:  1993-05       Impact factor: 5.407

5.  Associations of disease with genetic markers: déjà vu all over again.

Authors:  K K Kidd
Journal:  Am J Med Genet       Date:  1993-07-15

6.  The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration.

Authors:  H G Kraft; S Köchl; H J Menzel; C Sandholzer; G Utermann
Journal:  Hum Genet       Date:  1992-11       Impact factor: 4.132

7.  Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations.

Authors:  E Boerwinkle; C C Leffert; J Lin; C Lackner; G Chiesa; H H Hobbs
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

Review 8.  The pathogenesis of atherosclerosis: a perspective for the 1990s.

Authors:  R Ross
Journal:  Nature       Date:  1993-04-29       Impact factor: 49.962

9.  Characterization and localization of the FMR-1 gene product associated with fragile X syndrome.

Authors:  C Verheij; C E Bakker; E de Graaff; J Keulemans; R Willemsen; A J Verkerk; H Galjaard; A J Reuser; A T Hoogeveen; B A Oostra
Journal:  Nature       Date:  1993-06-24       Impact factor: 49.962

10.  Proliferation of human smooth muscle cells promoted by lipoprotein(a).

Authors:  D J Grainger; H L Kirschenlohr; J C Metcalfe; P L Weissberg; D P Wade; R M Lawn
Journal:  Science       Date:  1993-06-11       Impact factor: 47.728

View more
  19 in total

Review 1.  Lipoprotein(a): an elusive cardiovascular risk factor.

Authors:  Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-09-02       Impact factor: 8.311

2.  The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans.

Authors:  V Mooser; D Scheer; S M Marcovina; J Wang; R Guerra; J Cohen; H H Hobbs
Journal:  Am J Hum Genet       Date:  1997-08       Impact factor: 11.025

Review 3.  Structure, function, and genetics of lipoprotein (a).

Authors:  Konrad Schmidt; Asma Noureen; Florian Kronenberg; Gerd Utermann
Journal:  J Lipid Res       Date:  2016-04-13       Impact factor: 5.922

4.  Genetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk.

Authors:  James Ronald; Ramakrishnan Rajagopalan; Felecia Cerrato; Alex S Nord; Thomas Hatsukami; Ted Kohler; Santica Marcovina; Patrick Heagerty; Gail P Jarvik
Journal:  Stroke       Date:  2010-12-02       Impact factor: 7.914

5.  Inulin-enriched pasta affects lipid profile and Lp(a) concentrations in Italian young healthy male volunteers.

Authors:  Francesco Russo; Guglielmina Chimienti; Giuseppe Riezzo; Gabriella Pepe; Giuseppe Petrosillo; Marisa Chiloiro; Emanuele Marconi
Journal:  Eur J Nutr       Date:  2008-10-13       Impact factor: 5.614

6.  Scavenger receptor-BI is a receptor for lipoprotein(a).

Authors:  Xiao-Ping Yang; Marcelo J Amar; Boris Vaisman; Alexander V Bocharov; Tatyana G Vishnyakova; Lita A Freeman; Roger J Kurlander; Amy P Patterson; Lewis C Becker; Alan T Remaley
Journal:  J Lipid Res       Date:  2013-06-29       Impact factor: 5.922

7.  Lipoprotein(a): biology and clinical importance.

Authors:  Sally P A McCormick
Journal:  Clin Biochem Rev       Date:  2004-02

Review 8.  Lipoprotein (a): impact by ethnicity and environmental and medical conditions.

Authors:  Byambaa Enkhmaa; Erdembileg Anuurad; Lars Berglund
Journal:  J Lipid Res       Date:  2015-12-04       Impact factor: 5.922

9.  The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians.

Authors:  Jill Rubin; Han Jo Kim; Thomas A Pearson; Steve Holleran; Lars Berglund; Rajasekhar Ramakrishnan
Journal:  Atherosclerosis       Date:  2008-03-04       Impact factor: 5.162

10.  Apolipoprotein gene polymorphisms and plasma levels in healthy Tunisians and patients with coronary artery disease.

Authors:  Raoudha Bahri; Esther Esteban; Pedro Moral; Mohsen Hassine; Khaldoun Ben Hamda; Hassen Chaabani
Journal:  Lipids Health Dis       Date:  2008-11-17       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.